A disposable cartridge uses antibody-functionalized graphene to detect gluten proteins in food samples.
Automated FRET detection replaces manual Western blotting to measure C3a production, resolving low throughput and reliability bottlenecks.
Prothrombinase-induced clotting test identifies specific anticoagulants in plasma, resolving the trade-off between diagnostic reliability and time loss.
Engineered fluorescent binding proteins detect siderophores via signal changes, resolving low sensitivity in conventional microbial assays.
Antibody CDR engineering resolves cross-reactivity limits by enabling specific binding to human, monkey, and mouse ROR1 variants.
Artificial lipid bilayers mimic placental cell membranes to enable rapid molecular interaction studies.
A fluorescence counting system quantifies viruses using quantum crystal substrates and surface plasmon excitation.
The 32D6 monoclonal antibody binds to the H1N1 virus with high affinity to neutralize infection.
Biochemical hPL quantification replaces ultrasound scans, reducing equipment complexity while maintaining measurement precision.
A combination conjugate detects total gluten content in food samples using specific prolamin and glutelin antibodies.
Anti-hPG antibodies quantify progastrin levels in biological samples, replacing invasive endoscopic biopsies with a non-invasive diagnostic method.
Segmented antibody design resolves specificity contradictions against CD28, CTLA-4, ICOS, or BTLA while inhibiting immune evasion mechanisms.
Selective binders remove bound complexes to eliminate interference, enabling accurate measurement of free binding partners in immunoassays.
In vitro assays replace time-consuming in vivo models to evaluate Listeria immunotherapeutic potency via cytokine production measurements.
Multicolor flow cytometry with CD172a antibodies characterizes cardiac microvesicles, resolving diagnostic precision limits of conventional biomarkers.
Plasmonic scattering microscopy detects unlabeled biomolecules without fluorescent tags, preserving native protein complex structures for rare cell analysis.
Humanized EGFL6 monoclonal antibodies reduce immunogenicity while maintaining binding specificity to treat cancers.
Specific DNA aptamers bind monomeric CRP without cross-reacting with pentameric forms, enabling precise inflammation diagnostics.
A two-biomarker neoplasia index computes thymidine kinase and haptoglobin levels to differentiate feline lymphosarcoma from inflammatory bowel disease.
Imidazolidinyl urea preserves Zap-70 epitopes in stored blood samples, preventing degradation and enabling accurate clinical assays.
A placental cell culture model measures hormone secretion and P2X7 receptor activity to identify endocrine disruptors.
Anti-CDCP1 antibody binds CDCP1 protein to inhibit tumor cell proliferation and metastasis in cancers lacking effective targeted therapies.
Anti-IDO1 antibodies target the human IDO1 C-terminus, resolving limited material availability by enabling specific detection in biological samples.
Evaluating metallothionein expression via immunohistochemistry differentiates follicular adenoma from follicular cancer when scores reach eight or higher.
Molecularly-imprinted polymer coated conductive nanoparticles detect cotinine through electrical conductivity changes.
A reagent pair detects HT-2 toxin using specific binding partners that recognize the immune complex formed between the toxin and primary antibody.
A blood coagulation system analysis apparatus extracts clot parameters from whole blood dielectric changes.
Optimized CDR sequences achieve high affinity to resolve low antibody activity and cross-reaction interference in dengue detection.
A lateral flow assay detects beta-lactam and mycotoxin analytes using specific binders and a combined control zone.
Handheld magnetic particle spectroscopy devices detect biological substances using alternating magnetic fields and surface functionalized nanoparticles.
Picogram-sensitivity immunoassays extend detection windows beyond 24 hours, overcoming rapid metabolism limits.
Replacing complex chromatography with antibody-antigen recognition, the hybridoma strain enables rapid on-site dinitolmide residue detection in food.
A THLW peptide antibody detects HPV E6 antigens in saliva samples.
A lateral flow immunoassay uses recombinant antigens to detect HIV antibodies in biological specimens.
PSB-603 targets the adenosine A2B receptor to resolve limited efficacy in chronic pruritus treatments.
Self-assembled monolayer positions directly on metallic carrier within CMOS substrate to detect particles while lowering manufacturing cost and complexity.
Framework region back-mutations restore antibody conformation and binding affinity while minimizing immunogenicity for cancer diagnostics.
Two-dimensional transition metal dichalcogenide field-effect transistors detect biomolecules with high sensitivity.
Spatially segmented polypeptide detection resolves throughput and sensitivity trade-offs in complex biological samples.
A modified citrate buffer dissociates analyte-soluble target complexes, eliminating pre-treatment sample loss and improving quantification accuracy.
Anti-αvβ8 integrin antibodies target diseased kidney tissue to inhibit TGF-β activation, reducing fibrosis without off-target effects.
Antibody-conjugated beads enable rapid microorganism detection via Mie forward light scattering measurements.
Multi-marker fluorescent staining identifies 5T4-positive circulating tumor cells through digital microscopy analysis.
Microparticles coated with analyte-specific binding agents via PEG linkers reduce non-specific binding and improve signal-to-background ratios.
A molecularly imprinted polymer biosensor integrates electrocatalytic centers to enable direct redox reactions with target analytes.
Targeting conserved pre-fusion epitopes overcomes G protein diversity and palivizumab cost barriers.
Segmenting antibodies into small VHH fragments accelerates renal clearance, reducing background noise to improve early cancer detection sensitivity.